期刊语言：英语

出版地区：日本

万维提示

1、投稿方式：在线投稿。

2、期刊网址：

https://onlinelibrary.wiley.com/journal/13468138

3、投稿网址：http://mc.manuscriptcentral.com/jde

4、官网邮箱：jd@wiley.com

5、官网电话：+81 3 3830 1263

6、期刊刊期：月刊，一年出版12期。

2021年7月29日星期四

投稿须知【官网信息】

Author Guidelines

1. SUMMARY OF SUBMISSION REQUIREMENTS

Thank you for your interest in The Journal of Dermatology. Please read the complete Author Guidelines carefully prior to submission, including the section on copyright and publication charges.

Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at http://mc.manuscriptcentral.com/jde For help with submissions, please contact: jd@wiley.com

We look forward to your submission.

2. EDITORIAL CONSIDERATIONS

Aims and Scope

The Journal of Dermatology is the official peer-reviewed publication of the Japanese Dermatological Association and the Asian Dermatological Association. The journal aims to provide a forum for the exchange of information about new and significant research in dermatology and to promote the discipline of dermatology in Japan and throughout the world. Research articles are supplemented by reviews, theoretical articles, special features, commentaries, book reviews and proceedings of workshops and conferences. Preliminary or short reports and letters to the editor of two printed pages or less will be published as soon as possible. Papers in all fields of dermatology will be considered.

Editorial Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two reviewers and the Editors. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Final acceptance or rejection rests with the Editorial Board, who reserve the right to refuse any material for publication.

Ethical Considerations

Instructions: only relevant if your Journal publishes human studies

For manuscripts reporting medical studies involving human participants, we require a statement identifying the ethics committee that approved the study, and that the study conforms to recognized standards, for example:

• Declaration of Helsinki

• US Federal Policy for the Protection of Human Subjects

• European Medicines Agency Guidelines for Good Clinical Practice

Photographic Consents

A letter of consent must accompany all photographs of patients in which a possibility of identification exists. It is not sufficient to cover the eyes to mask identity.

Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Patient anonymity should be preserved. Non-essential identifying details should be omitted.

Editors may request that reviewers comment on the standard of experimental reporting, experimental design, or any other aspects of the study reported that may cause concern. If concerns are raised or clarifications are needed, we may need to request evidence of ethical research approval.

Conflict of Interest

We require that all authors disclose any potential sources of conflict of interest. The existence of a conflict of interest does not preclude publication. A conflict of interest statement must be included within the manuscript (see section ‘Parts of the Manuscript’), and authors must also complete a Conflict of Interest form. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company.

To download Conflict of Interest form, please click here. Completion the form is mandatory for all article categories.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

Authorship

The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and iv) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, The Journal of Dermatology will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

ORCID

As part of our commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript.

This takes around 2 minutes to complete. Find more information.

COPE

This journal is a member of the Committee on Publication Ethics (COPE). Publication ethics guidelines can also be found at http://exchanges.wiley.com/ethicsguidelines.

Acceptable secondary publication

Secondary publication in the same or another language, especially in other countries, is justifiable and can be beneficial provided that the following conditions are met.

The authors have received approval from the editors of both journals; the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version.

The priority of the primary publication is respected by a publication interval of at least 1 week (unless specifically negotiated otherwise by both editors).

The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.

The secondary version faithfully reflects the authors, data and interpretations of the primary version.

The footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part and states the primary reference. A suitable footnote might read: “This article is based on a study first reported in the [title of journal, with full reference].

Please see here for further information.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Original Articles

Word limit: 6,000 words including abstract

Abstract: Unstructured (up to 300 words)

Figures/Tables: No limit

References: No limit

Description: Arrange text as follows: (i) title page, (ii) abstract and key words, (iii) text (divided into sections with the headings: Introduction, Methods, Results, Discussion), (iv) acknowledgments, (v) conflict of interest, (vi) references, (vii) supporting information, (viii) figure legends, (ix) tables (each table complete with title and footnotes) and (x) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Concise Communication

Word limit: 1,500 words including abstract

Abstract: Unstructured (up to 300 words)

Figures/Tables: Up to 3 (Multi panel figures must be compiled into one figure.)

References: Up to 15

Description: (a) A case report with mini review or with new observations of diseases, clinical findings or novel treatment outcomes; OR (b) a brief research paper. Arrange text as follows: (i) title page, (ii)abstract and key words, (iii) text (divided into sections with the headings: (a) Introduction, Case Report, Discussion or (b) Introduction, Methods, Results, Discussion) (iv)acknowledgments, (v) conflict of interest, (vi) references, (vii) supporting information, (viii) figure legends, (ix) tables (each table complete with title and footnotes) and (x) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Research Notes

Word limit: 750 words

Authors: Maximum 5 authors

Abstract: No abstract

References: Up to 7

Figures/ tables: Up to 1 (Multi panel figures must be compiled into one figure. Additional tables/figures should be submitted as Supporting Information.)

Description: Research Notes are brief summary of interesting findings in basic research, reporting preliminary data relevant to the field. It should not include a detailed report or discussion but a concise and short description of the data and the findings.

Review Articles

Word limit: 5,000 words including abstract

Abstract: Unstructured (up to 300 words)

References: No limit

Figures/tables: No limit. (Minimum 1 image or figure)

Description: Reviews are comprehensive analyses of specific topics. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

Letters to the Editor

Word limit: 500 words

Authors: Maximum ten authors

Abstract: No abstract

References: Up to 5

Figures/tables: Up to 1 (Multi panel figures must be compiled into one figure.)

Description: The journal publishes two types of Letters to the Editor, listed below. Letters to the Editor of one printed pages or less will be published as soon as possible.

(i) Notes & Comments: Letters may be submitted to the Editor on any topic of discussion; clinical observations as well as letters commenting on papers published in recent issues.

(ii) Case Letters: Conclusions based on uncontrolled trials and/or limited experience should be stated in appropriately tentative terms. Concise descriptions detailing one or two patients, early reports of therapeutic trials in one or several patients, and early reports of new drug reactions.

Letters to the Editor will be published in the only Online edition from 2017.

4. PREPARING THE MANUSCRIPT

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Writing for Search Engine Optimization

Optimize the search engine results for your paper, so people can find, read and ultimately cite your work. Simply read our best practice SEO tips – including information on making your title and abstract SEO-friendly, and choosing appropriate keywords. Click here for the 4 easy steps to SEO.

Preprint policy

Please find the Wiley preprint policy here. This journal accepts articles previously published on preprint servers.

The Journal of Dermatology will consider for review articles previously available as preprints. You may also post the submitted version of a manuscript to a preprint server at any time. You are requested to update any pre-publication versions with a link to the final published article.

Data Sharing and Data Availability

This journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation policy.

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley’s Data Protection Policy to learn more.

Manuscript Style

Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org.

Spelling: The journal uses US spelling and authors should therefore follow the latest edition of the Merriam-Webster’s Collegiate Dictionary.

Units: All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at https://www.bipm.org/en/about-us/ for more information about SI units.

Abbreviations: Abbreviations should be used sparingly -only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Trade names: Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.

Parts of the Manuscript

The length of manuscripts must adhere to the specifications under the section Manuscript Categories.

Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) conflict of interest statement, (vi) references, (viii) figure legends, and (ix) tables (each table complete with title and footnotes). Figures and supporting information should be supplied in separate files.

……

更多详情：

https://onlinelibrary.wiley.com/page/journal/13468138/homepage/forauthors.html